Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome

BackgroundThe role of excess androgen in ovarian reserve remains unclear in patients with polycystic ovary syndrome (PCOS). Our study highlights the associations of serum androgen levels and ovarian reserve markers in PCOS and non-PCOS women.MethodsTotally 584 menstrual abnormalities women of 20-45...

Full description

Bibliographic Details
Main Authors: Youran Li, Yanhong Zhai, Lin Li, Yifan Lu, Shaofei Su, Ying Liu, Zhengwen Xu, Mingwei Xin, Qiaoli Zhang, Zheng Cao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.881740/full
_version_ 1817969334319841280
author Youran Li
Youran Li
Yanhong Zhai
Yanhong Zhai
Lin Li
Yifan Lu
Yifan Lu
Shaofei Su
Ying Liu
Ying Liu
Zhengwen Xu
Zhengwen Xu
Mingwei Xin
Qiaoli Zhang
Zheng Cao
Zheng Cao
author_facet Youran Li
Youran Li
Yanhong Zhai
Yanhong Zhai
Lin Li
Yifan Lu
Yifan Lu
Shaofei Su
Ying Liu
Ying Liu
Zhengwen Xu
Zhengwen Xu
Mingwei Xin
Qiaoli Zhang
Zheng Cao
Zheng Cao
author_sort Youran Li
collection DOAJ
description BackgroundThe role of excess androgen in ovarian reserve remains unclear in patients with polycystic ovary syndrome (PCOS). Our study highlights the associations of serum androgen levels and ovarian reserve markers in PCOS and non-PCOS women.MethodsTotally 584 menstrual abnormalities women of 20-45 years were retrospectively evaluated at the Beijing Obstetrics and Gynecology Hospital between January 2021 to October 2021. The enrolled patients were classified into two groups: the PCOS group (n=288) and the non-PCOS group (n=296) based on the Rotterdam consensus for PCOS diagnosis. The serum androgens, including testosterone (T), free testosterone (FT, calculated), bioavailable testosterone (Bio-T, calculated), androstenedione (A2), dihydrotestosterone (DHT), dehydroepiandrosterone (DHEA), and dehydroepiandrosterone sulfate (DHEAS) were assessed with an in-house developed liquid chromatography tandem mass spectrometry (LC-MS/MS) method. The associations between the serum androgens and the hormone markers commonly used for evaluating ovarian reserve function, such as anti-mullerian hormone (AMH) and the ratio of luteinizing hormone (LH)/follicle stimulating hormone (FSH) were explored.ResultsThe serum T, FT, Bio-T, A2, DHT, DHEA, DHEAS, AMH and LH/FSH of the PCOS group were 51.7 ± 23.2 ng/dL/mL, 8.5 ± 5.0 pg/mL, 210.1 ± 127.7 pg/mL, 1.9 ± 0.8 ng/mL, 0.2 ± 0.1 ng/mL, 6.4 ± 4.2 ng/mL, 2431.0 ± 1030.7 ng/mL, 6.7 ± 3.8 ng/mL, and 1.8 ± 1.4 respectively, which were significantly higher than those in the non-PCOS group (p<0.05). In the group of PCOS patients, T and A2 levels were positively associated with AMH in both multivariate linear regression analysis and Pearson’s correlation analysis. Similar but weaker associations were observed in the non-PCOS patients. In the PCOS patients with hyperandrogenemia (HA), the AMH level was significantly higher in the subjects with T increased than in the subjects with non-T androgen(s) increased (A2, DHT, DHEA or DHEAS).ConclusionsThe serum androgen levels are positively associated with ovarian reserve markers in both of the PCOS and the non-PCOS patients in our study. In the PCOS group, the highest AMH level was observed in the subjects with the T elevation subgroup, suggesting that T is more closely related with the increase of AMH when compared with other androgens investigated.
first_indexed 2024-04-13T20:19:56Z
format Article
id doaj.art-2d08cc6f8e5d49bab92fbbe94907add3
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-13T20:19:56Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-2d08cc6f8e5d49bab92fbbe94907add32022-12-22T02:31:35ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-06-011310.3389/fendo.2022.881740881740Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary SyndromeYouran Li0Youran Li1Yanhong Zhai2Yanhong Zhai3Lin Li4Yifan Lu5Yifan Lu6Shaofei Su7Ying Liu8Ying Liu9Zhengwen Xu10Zhengwen Xu11Mingwei Xin12Qiaoli Zhang13Zheng Cao14Zheng Cao15Department of Laboratory Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaCenter of Clinical Mass Spectrometry, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaDepartment of Laboratory Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaCenter of Clinical Mass Spectrometry, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaCentral Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaDepartment of Laboratory Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaCenter of Clinical Mass Spectrometry, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaCentral Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaDepartment of Laboratory Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaCenter of Clinical Mass Spectrometry, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaDepartment of Laboratory Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaCenter of Clinical Mass Spectrometry, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaDepartment of Traditional Chinese Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaDepartment of Human Reproductive Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaDepartment of Laboratory Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaCenter of Clinical Mass Spectrometry, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaBackgroundThe role of excess androgen in ovarian reserve remains unclear in patients with polycystic ovary syndrome (PCOS). Our study highlights the associations of serum androgen levels and ovarian reserve markers in PCOS and non-PCOS women.MethodsTotally 584 menstrual abnormalities women of 20-45 years were retrospectively evaluated at the Beijing Obstetrics and Gynecology Hospital between January 2021 to October 2021. The enrolled patients were classified into two groups: the PCOS group (n=288) and the non-PCOS group (n=296) based on the Rotterdam consensus for PCOS diagnosis. The serum androgens, including testosterone (T), free testosterone (FT, calculated), bioavailable testosterone (Bio-T, calculated), androstenedione (A2), dihydrotestosterone (DHT), dehydroepiandrosterone (DHEA), and dehydroepiandrosterone sulfate (DHEAS) were assessed with an in-house developed liquid chromatography tandem mass spectrometry (LC-MS/MS) method. The associations between the serum androgens and the hormone markers commonly used for evaluating ovarian reserve function, such as anti-mullerian hormone (AMH) and the ratio of luteinizing hormone (LH)/follicle stimulating hormone (FSH) were explored.ResultsThe serum T, FT, Bio-T, A2, DHT, DHEA, DHEAS, AMH and LH/FSH of the PCOS group were 51.7 ± 23.2 ng/dL/mL, 8.5 ± 5.0 pg/mL, 210.1 ± 127.7 pg/mL, 1.9 ± 0.8 ng/mL, 0.2 ± 0.1 ng/mL, 6.4 ± 4.2 ng/mL, 2431.0 ± 1030.7 ng/mL, 6.7 ± 3.8 ng/mL, and 1.8 ± 1.4 respectively, which were significantly higher than those in the non-PCOS group (p<0.05). In the group of PCOS patients, T and A2 levels were positively associated with AMH in both multivariate linear regression analysis and Pearson’s correlation analysis. Similar but weaker associations were observed in the non-PCOS patients. In the PCOS patients with hyperandrogenemia (HA), the AMH level was significantly higher in the subjects with T increased than in the subjects with non-T androgen(s) increased (A2, DHT, DHEA or DHEAS).ConclusionsThe serum androgen levels are positively associated with ovarian reserve markers in both of the PCOS and the non-PCOS patients in our study. In the PCOS group, the highest AMH level was observed in the subjects with the T elevation subgroup, suggesting that T is more closely related with the increase of AMH when compared with other androgens investigated.https://www.frontiersin.org/articles/10.3389/fendo.2022.881740/fullandrogenovarian reservePCOSLC-MS/MSAMH
spellingShingle Youran Li
Youran Li
Yanhong Zhai
Yanhong Zhai
Lin Li
Yifan Lu
Yifan Lu
Shaofei Su
Ying Liu
Ying Liu
Zhengwen Xu
Zhengwen Xu
Mingwei Xin
Qiaoli Zhang
Zheng Cao
Zheng Cao
Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
Frontiers in Endocrinology
androgen
ovarian reserve
PCOS
LC-MS/MS
AMH
title Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
title_full Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
title_fullStr Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
title_full_unstemmed Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
title_short Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
title_sort divergent associations between serum androgens and ovarian reserve markers revealed in patients with polycystic ovary syndrome
topic androgen
ovarian reserve
PCOS
LC-MS/MS
AMH
url https://www.frontiersin.org/articles/10.3389/fendo.2022.881740/full
work_keys_str_mv AT youranli divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT youranli divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT yanhongzhai divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT yanhongzhai divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT linli divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT yifanlu divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT yifanlu divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT shaofeisu divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT yingliu divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT yingliu divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT zhengwenxu divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT zhengwenxu divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT mingweixin divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT qiaolizhang divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT zhengcao divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome
AT zhengcao divergentassociationsbetweenserumandrogensandovarianreservemarkersrevealedinpatientswithpolycysticovarysyndrome